Chen G, Hitomi M, Han J, Stacey D W
Cleveland Clinic Foundation, Department of Molecular Biology, Cleveland, Ohio 44195, USA.
J Biol Chem. 2000 Dec 15;275(50):38973-80. doi: 10.1074/jbc.M002856200.
Ras activates three mitogen-activated protein kinases (MAPKs) including ERK, JNK, and p38. Whereas the essential roles of ERK and JNK in Ras signaling has been established, the contribution of p38 remains unclear. Here we demonstrate that the p38 pathway functions as a negative regulator of Ras proliferative signaling via a feedback mechanism. Oncogenic Ras activated p38 and two p38-activated protein kinases, MAPK-activated protein kinase 2 (MK2) and p38-related/activated protein kinase (PRAK). MK2 and PRAK in turn suppressed Ras-induced gene expression and cell proliferation, whereas two mutant PRAKs, unresponsive to Ras, had little effect. Moreover, the constitutive p38 activator MKK6 also suppressed Ras activity in a p38-dependent manner whereas arsenite, a potent chemical inducer of p38, inhibited proliferation only in a tumor cell line that required Ras activity. MEK was required for Ras stimulation of the p38 pathway. The p38 pathway inhibited Ras activity by blocking activation of JNK, without effect upon ERK, as evidenced by the fact that PRAK-mediated suppression of Ras-induced cell proliferation was reversed by coexpression of JNKK2 or JNK1. These studies thus establish a negative feedback mechanism by which Ras proliferative activity is regulated via signaling integrations of MAPK pathways.
Ras激活三种丝裂原活化蛋白激酶(MAPK),包括细胞外信号调节激酶(ERK)、c-Jun氨基末端激酶(JNK)和p38。虽然ERK和JNK在Ras信号传导中的重要作用已经明确,但p38的作用仍不清楚。在此我们证明,p38通路通过反馈机制作为Ras增殖信号的负调节因子。致癌性Ras激活p38以及两种p38激活的蛋白激酶,即丝裂原活化蛋白激酶激活的蛋白激酶2(MK2)和p38相关/激活蛋白激酶(PRAK)。MK2和PRAK继而抑制Ras诱导的基因表达和细胞增殖,而两种对Ras无反应的突变型PRAK则几乎没有作用。此外,组成型p38激活剂MKK6也以p38依赖的方式抑制Ras活性,而亚砷酸盐(一种有效的p38化学诱导剂)仅在需要Ras活性的肿瘤细胞系中抑制增殖。MEK是Ras刺激p38通路所必需的。p38通路通过阻断JNK的激活来抑制Ras活性,而对ERK没有影响,这一点可由以下事实证明:共表达JNKK2或JNK1可逆转PRAK介导的对Ras诱导的细胞增殖的抑制作用。因此,这些研究建立了一种负反馈机制,通过该机制,Ras的增殖活性通过MAPK通路的信号整合来调节。